TIDMAMC

RNS Number : 3732J

Amur Minerals Corporation

15 August 2023

15 August 2023

Amur Minerals Corporation

("Amur" or the "Company")

Cash shell update

Further to the announcement of 6 March 2023 and the disposal of the Company's AO Kun-Manie subsidiary, following which Amur became an AIM Rule 15 cash shell, the board of Amur notes that the Company is required to make an acquisition or acquisitions which constitute(s) a reverse takeover under AIM Rule 14 on or before the date falling six months from the completion of the AO Kun-Manie disposal.

Accordingly, if no such transaction is completed, the Company will be suspended from trading on AIM at 7.30 a.m. on 7 September 2023. Once suspended, Amur will have a further six months to complete a reverse takeover or else admission of the Company's shares on AIM will be cancelled on 8 March 2024.

The board of Amur continues to review a number of reverse takeover opportunities. Further announcements will be made as appropriate.

Enquiries:

 
       Company            Nomad and Broker        Public Relations 
  Amur Minerals Corp.    S.P. Angel Corporate         BlytheRay 
                             Finance LLP 
   Robin Young CEO        Richard Morrison           Megan Ray 
                              Adam Cowl              Tim Blythe 
                           +44 (0) 20 3470 
 +44 (0) 7981 126 818            0470           +44 (0) 20 7138 3203

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCVELBFXVLLBBV

(END) Dow Jones Newswires

August 15, 2023 04:30 ET (08:30 GMT)

Crism Therapeutics (AQSE:AMC.GB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Crism Therapeutics.
Crism Therapeutics (AQSE:AMC.GB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Crism Therapeutics.